Supplementary Data from N6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer

Proteins identified in RNA pulldown and mass spectrometry analysis with FZR1[m6A] or FZR1[A].

Gardado en:

Detalles Bibliográficos
Autor Principal:	Jiachun Su (16990970) (author)
Outros autores:	Rui Li (16990973) (author), Ziming Chen (16990976) (author), Shaoqiu Liu (16990979) (author), Hongzhe Zhao (16990982) (author), Shuang Deng (16990985) (author), Lingxing Zeng (16990988) (author), Zilan Xu (16990991) (author), Sihan Zhao (16990994) (author), Yifan Zhou (16990997) (author), Mei Li (16991000) (author), Xiaowei He (16991003) (author), Ji Liu (16991006) (author), Chunling Xue (16991009) (author), Ruihong Bai (16991012) (author), Lisha Zhuang (16991015) (author), Quanbo Zhou (16991018) (author), Shaoping Zhang (16991021) (author), Rufu Chen (16991024) (author), Xudong Huang (16991027) (author), Dongxin Lin (16991030) (author), Jian Zheng (11732682) (author), Jialiang Zhang (16991033) (author)
Publicado:	2025
Subjects:	Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Chemotherapy Drug Resistance Regulation of gene expression in drug resistance Epigenetics Gastrointestinal Cancers Pancreatic cancer
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

_version_	1849927637633335296
author	Jiachun Su (16990970)
author2	Rui Li (16990973) Ziming Chen (16990976) Shaoqiu Liu (16990979) Hongzhe Zhao (16990982) Shuang Deng (16990985) Lingxing Zeng (16990988) Zilan Xu (16990991) Sihan Zhao (16990994) Yifan Zhou (16990997) Mei Li (16991000) Xiaowei He (16991003) Ji Liu (16991006) Chunling Xue (16991009) Ruihong Bai (16991012) Lisha Zhuang (16991015) Quanbo Zhou (16991018) Shaoping Zhang (16991021) Rufu Chen (16991024) Xudong Huang (16991027) Dongxin Lin (16991030) Jian Zheng (11732682) Jialiang Zhang (16991033)
author2_role	author author author author author author author author author author author author author author author author author author author author author author
author_facet	Jiachun Su (16990970) Rui Li (16990973) Ziming Chen (16990976) Shaoqiu Liu (16990979) Hongzhe Zhao (16990982) Shuang Deng (16990985) Lingxing Zeng (16990988) Zilan Xu (16990991) Sihan Zhao (16990994) Yifan Zhou (16990997) Mei Li (16991000) Xiaowei He (16991003) Ji Liu (16991006) Chunling Xue (16991009) Ruihong Bai (16991012) Lisha Zhuang (16991015) Quanbo Zhou (16991018) Shaoping Zhang (16991021) Rufu Chen (16991024) Xudong Huang (16991027) Dongxin Lin (16991030) Jian Zheng (11732682) Jialiang Zhang (16991033)
author_role	author
dc.creator.none.fl_str_mv	Jiachun Su (16990970) Rui Li (16990973) Ziming Chen (16990976) Shaoqiu Liu (16990979) Hongzhe Zhao (16990982) Shuang Deng (16990985) Lingxing Zeng (16990988) Zilan Xu (16990991) Sihan Zhao (16990994) Yifan Zhou (16990997) Mei Li (16991000) Xiaowei He (16991003) Ji Liu (16991006) Chunling Xue (16991009) Ruihong Bai (16991012) Lisha Zhuang (16991015) Quanbo Zhou (16991018) Shaoping Zhang (16991021) Rufu Chen (16991024) Xudong Huang (16991027) Dongxin Lin (16991030) Jian Zheng (11732682) Jialiang Zhang (16991033)
dc.date.none.fl_str_mv	2025-11-24T23:24:02Z
dc.identifier.none.fl_str_mv	10.1158/0008-5472.30701255
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Supplementary_Data_from_i_N_i_sup_6_sup_-methyladenosine_Modification_of_FZR1_mRNA_Promotes_Gemcitabine_Resistance_in_Pancreatic_Cancer/30701255
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Chemotherapy Drug Resistance Regulation of gene expression in drug resistance Epigenetics Gastrointestinal Cancers Pancreatic cancer
dc.title.none.fl_str_mv	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Proteins identified in RNA pulldown and mass spectrometry analysis with FZR1[m6A] or FZR1[A].</p>
eu_rights_str_mv	openAccess
id	Manara_5887da2403b26b76375998f6bda7c4ca
identifier_str_mv	10.1158/0008-5472.30701255
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30701255
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic CancerJiachun Su (16990970)Rui Li (16990973)Ziming Chen (16990976)Shaoqiu Liu (16990979)Hongzhe Zhao (16990982)Shuang Deng (16990985)Lingxing Zeng (16990988)Zilan Xu (16990991)Sihan Zhao (16990994)Yifan Zhou (16990997)Mei Li (16991000)Xiaowei He (16991003)Ji Liu (16991006)Chunling Xue (16991009)Ruihong Bai (16991012)Lisha Zhuang (16991015)Quanbo Zhou (16991018)Shaoping Zhang (16991021)Rufu Chen (16991024)Xudong Huang (16991027)Dongxin Lin (16991030)Jian Zheng (11732682)Jialiang Zhang (16991033)CancerCancer Risk FactorsMolecular and Cellular BiologyTherapeutic Research and DevelopmentChemotherapyDrug ResistanceRegulation of gene expression in drug resistanceEpigeneticsGastrointestinal CancersPancreatic cancer<p>Proteins identified in RNA pulldown and mass spectrometry analysis with FZR1[m6A] or FZR1[A].</p>2025-11-24T23:24:02ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/0008-5472.30701255https://figshare.com/articles/dataset/Supplementary_Data_from_i_N_i_sup_6_sup_-methyladenosine_Modification_of_FZR1_mRNA_Promotes_Gemcitabine_Resistance_in_Pancreatic_Cancer/30701255CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307012552025-11-24T23:24:02Z
spellingShingle	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer Jiachun Su (16990970) Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Chemotherapy Drug Resistance Regulation of gene expression in drug resistance Epigenetics Gastrointestinal Cancers Pancreatic cancer
status_str	publishedVersion
title	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
title_full	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
title_fullStr	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
title_full_unstemmed	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
title_short	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
title_sort	Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
topic	Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Chemotherapy Drug Resistance Regulation of gene expression in drug resistance Epigenetics Gastrointestinal Cancers Pancreatic cancer

Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer

Títulos similares